Peer Review History
| Original SubmissionAugust 17, 2025 |
|---|
|
PONE-D-25-44538 Refining Weak Supervision for Robust Lung Cavity Segmentation: A Graph-Affinity Framework with Boundary Constraints PLOS One Dear Dr. Tan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 26 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hongchuan Yu Academic Editor PLOS One Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: I invite 2 reviewers and their recommend: Both minor. Reviewers have some concerns such as 1) novelty is weak, 2) dataset transparency, experimental reproducibility, and fair benchmarking... Hope their comments are helpful for you to improve this work. Finally, I will recommend "Minor" to this paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript addresses a clinically relevant and technically challenging task—weakly supervised lung cavity segmentation in CT imaging—by proposing a graph-based affinity network (GA-Net) with additional refinements such as EMA ensembling and a scribble-based boundary module. The topic aligns well with PLOS ONE’s scope in medical AI and image analysis. The writing is generally clear, and the technical presentation is well-structured. However, several critical issues related to clarity of contribution, dataset transparency, experimental reproducibility, and fair benchmarking must be resolved before the paper can be considered for publication. Comments: 1. Clarity of Contribution The paper repeatedly refers to the proposed work as a framework, but from the methodology and experiment sections, it is essentially a new method or model (GA-Net) rather than a broader framework. Recommendation: Re-define the contribution precisely. The abstract and introduction should explicitly highlight what is new compared to previous WSSS methods. Currently, the novelty statement is diffuse. 2. Literature Review and Dataset Exploration The related work section (implied within the introduction) briefly mentions previous WSSS and medical segmentation works but does not adequately analyse key prior methods or datasets. 3. Dataset and Experimental Specification The dataset description is too brief and does not indicate: Imaging modalities (CT resolution, slice count), Preprocessing steps (normalisation, lung mask extraction, augmentation), How image-level or scribble labels were generated, Hardware/software environment. Some “processing seems missing,” e.g., how the pseudo-labels are derived and refined, and how scribbles are converted into supervision masks. 4. It is good to have a detailed subsection “Dataset and Preprocessing” and another “Implementation Details” under Methodology or Experiments. 5. Benchmarking and Fairness of Comparison The results claim superiority over state-of-the-art WSSS techniques but provide no clear justification that comparisons are fair. It is good to include a concise Benchmark Configuration Table listing each compared method, supervision type, and training protocol to demonstrate fairness and consistency. 6. The paper does not analyse the computational cost or complexity of GA-Net. It is good to add a complexity discussion. It would strengthen the argument for practical robustness, particularly for clinical deployment. 7. Equations (1)–(9) are mathematically dense but lack intuitive explanation or pseudocode showing how the modules are trained end-to-end. Reviewer #2: Overall, the manuscript appears to present a coherent and potentially valuable contribution to weakly supervised 3D lung cavity segmentation, with a plausible methodological rationale, multi-dataset evaluation, and ablations that generally support the main claims of incremental performance improvement. However, the current version would benefit from important clarifications and modest strengthening. 1. The manuscript mentions both fixed splits and 5-fold CV. Please clarify whether CV was limited to the training set with a held-out test set, and how hyper-parameters were chosen to prevent test leakage. 2. If the authors report significance, they should specify the tests and justify their assumptions. Fold-wise paired tests or bootstrap CIs for DSC/IoU would be more appropriate than t-tests on correlated training losses. 3. Key hyper-parameters (affinity thresholds, graph design, propagation settings) may strongly affect results; a brief robustness/sensitivity analysis would show the gains are not dependent on a narrowly tuned setup. 4. The gains over baselines are encouraging, but absolute DSC/IoU remain modest; the discussion should focus on relative improvements and avoid implying clinical readiness without further validation. 5. Add qualitative and quantitative subgroup analyses by lesion size, location, morphology, and severity to clarify where the method performs well and where it fails. 6. The manuscript is well organised and mostly clear, with generally standard English. However, the experimental protocol and parts of the methods would benefit from language polishing to improve clarity and consistency in terminology, acronyms, and the evaluation design. 7. The statistics support descriptive improvement claims, but the inferential evidence is not yet robust, particularly given the t-test usage and unclear CV design. Clearer protocol details and fold- or patient-level testing would strengthen the conclusions. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Armin Sheibanifard ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Refining Weak Supervision for Robust Lung Cavity Segmentation: A Graph-Affinity Method with Boundary Constraints PONE-D-25-44538R1 Dear Dr. Madzin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hongchuan Yu Academic Editor PLOS One Additional Editor Comments (optional): no further comments Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-44538R1 PLOS One Dear Dr. Madzin, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hongchuan Yu Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .